Alpha Cognition Announces Grant of Stock Options
businesswire.com
news
2022-05-31 00:00:00

May 31, 2022 05:38 PM Eastern Daylight Time VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) ('Alpha Cognition,' or the 'Company'), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, announces the grant of stock options pursuant to its stock option plan to certain directors of the Company to purchase up to an aggregate of 400,000 common shares of the Company.
